Meg Krench is an experienced professional currently serving as an Investor at Sanofi Ventures since August 2021, while also holding various board observer positions at Draig Therapeutics, Eligo Bioscience, QurAlis, and Normunity. In addition, Meg Krench serves as a Board Director for VERALOX Therapeutics and is a Board Co-Chair and Board Director at New England Venture Network. Meg's academic background includes a PhD in Neuroscience from the Massachusetts Institute of Technology and a BS in Biology with a focus on Neuroscience from Penn State University. Previous experience includes a role as Director of Business Development - External Innovation at Vertex Pharmaceuticals.
This person is not in the org chart
This person is not in any teams
This person is not in any offices